Publications en collaboration avec des chercheurs de Hospital Universitario Doctor Peset (156)

2024

  1. Beyond Weight Loss: Evaluating Cardiovascular Advantages of GLP-1 Receptor Agonists

    American Journal of Cardiovascular Drugs

  2. Cardiovascular benefits of SGLT2 inhibitors and GLP-1 receptor agonists through effects on mitochondrial function and oxidative stress

    Free Radical Biology and Medicine, Vol. 213, pp. 19-35

  3. Circadian alignment of food intake and glycaemic control by time-restricted eating: A systematic review and meta-analysis

    Reviews in Endocrine and Metabolic Disorders, Vol. 25, Núm. 2, pp. 325-337

  4. Correction to: Differential effectiveness of tyrosine kinase inhibitors in 2D/3D culture according to cell differentiation, p53 status and mitochondrial respiration in liver cancer cells (Cell Death & Disease, (2020), 11, 5, (339), 10.1038/s41419-020-2558-1)

    Cell Death and Disease

  5. Inflammation and weight change related to neurocognitive and functional impairment in diabetes and psychiatric disorders

    Spanish Journal of Psychiatry and Mental Health

  6. Molecular circadian clock disruption in the leukocytes of individuals with type 2 diabetes and overweight, and its relationship with leukocyte–endothelial interactions

    Diabetologia

  7. SIRT1 and miR-34a-5p: Valuable Biomarkers for the Early Detection of Cognitive Impairment in Type 2 Diabetes Mellitus

    Journal of Clinical Endocrinology and Metabolism

  8. Systemic inflammation, oxidative damage and neurocognition predict telomere length in a transdiagnostic sample stratified by global DNA methylation levels

    Scientific Reports, Vol. 14, Núm. 1

2023

  1. Effects of GLP-1 receptor agonists on mitochondrial function, inflammatory markers and leukocyte-endothelium interactions in type 2 diabetes

    Redox biology, Vol. 66, pp. 102849

  2. Inflammation and lipid metabolism as potential biomarkers of memory impairment across type 2 diabetes mellitus and severe mental disorders

    Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 127

  3. Mitochondrial Dysfunction and Mitophagy in Type 2 Diabetes: Pathophysiology and Therapeutic Targets

    Antioxidants and Redox Signaling, Vol. 39, Núm. 4-6, pp. 278-320

2022

  1. Glycated Proteins, Glycine, Acetate, and Monounsaturated Fatty Acids May Act as New Biomarkers to Predict the Progression of Type 2 Diabetes: Secondary Analyses of a Randomized Controlled Trial

    Nutrients, Vol. 14, Núm. 23

  2. Gold Nanoparticles Supported on Ceria Nanoparticles Modulate Leukocyte–Endothelium Cell Interactions and Inflammation in Type 2 Diabetes

    Antioxidants, Vol. 11, Núm. 11

  3. Immune–Inflammatory Biomarkers Predict Cognition and Social Functioning in Patients With Type 2 Diabetes Mellitus, Major Depressive Disorder, Bipolar Disorder, and Schizophrenia: A 1-Year Follow-Up Study

    Frontiers in Neurology, Vol. 13

  4. Impact of Roux-en-Y Gastric Bypass on Mitochondrial Biogenesis and Dynamics in Leukocytes of Obese Women

    Antioxidants, Vol. 11, Núm. 7

  5. Impact of nitric oxide in liver cancer microenvironment

    Nitric Oxide - Biology and Chemistry, Vol. 128, pp. 1-11

  6. Metformin modulates mitochondrial function and mitophagy in peripheral blood mononuclear cells from type 2 diabetic patients

    Redox Biology, Vol. 53

  7. Metformin: An Intriguing Protective Agent in Hospitalized Diabetic Patients With Sepsis

    Critical care medicine, Vol. 50, Núm. 6, pp. 1018-1020

  8. Mitochondrial redox impairment and enhanced autophagy in peripheral blood mononuclear cells from type 1 diabetic patients

    Redox Biology, Vol. 58

  9. Roux-en-Y Gastric Bypass Modulates AMPK, Autophagy and Inflammatory Response in Leukocytes of Obese Patients

    Biomedicines, Vol. 10, Núm. 2